L-글루타민

Effect of glutamine supplementation on inflammatory markers in critically ill patients supported with enteral or parenteral feeding.

1. JPEN J Parenter Enteral Nutr. 2022 Jan;46(1):61-68. doi: 10.1002/jpen.2217. Epub 2021 Aug 16. Effect of glutamine supplementation on inflammatory markers in critically ill patients supported with enteral or parenteral feeding. Gholamalizadeh M(1), Tabrizi R(2), Rezaei S(3)(4), Badeli M(5), Sh

Effect of Huiyang Shengji unguent on the NOD-like receptor family pyrin domain containing protein 3/caspase1/ gasdermin D pathway and lymphatic angiogenesis in patients with diabetic foot ulcer.

2. J Tradit Chin Med. 2026 Apr;46(2):427-438. doi: 10.19852/j.cnki.jtcm.2026.02.015. Effect of Huiyang Shengji unguent on the NOD-like receptor family pyrin domain containing protein 3/caspase1/ gasdermin D pathway and lymphatic angiogenesis in patients with diabetic foot ulcer. Fangning YU(1),

Impact of preoperative beta-hydroxy-beta-methylbutyrate, arginine, and glutamine supplementation on inflammation in patients with cardiac surgery: A secondary analysis of a randomized controlled trial.

3. J Cardiol. 2025 Dec;86(6):561-567. doi: 10.1016/j.jjcc.2025.08.017. Epub 2025 Sep 4. Impact of preoperative beta-hydroxy-beta-methylbutyrate, arginine, and glutamine supplementation on inflammation in patients with cardiac surgery: A secondary analysis of a randomized controlled trial. Ogawa

L-arginine vs. L-glutamine oral suspensions for radiation-induced oral mucositis: a triple-blind randomized trial.

4. J Cancer Res Clin Oncol. 2025 Jul 3;151(7):198. doi: 10.1007/s00432-025-06213-x. L-arginine vs. L-glutamine oral suspensions for radiation-induced oral mucositis: a triple-blind randomized trial. Hassanein FEA(1), Mikhail C(2)(3), Elkot S(4), Abou-Bakr A(5). Author information: (1)Oral Medici

Effects of L-glutamine and hyaluronic acid associated with photobiomodulation on oral mucositis: a randomized clinical trial.

5. Support Care Cancer. 2025 Apr 28;33(5):430. doi: 10.1007/s00520-025-09480-z. Effects of L-glutamine and hyaluronic acid associated with photobiomodulation on oral mucositis: a randomized clinical trial. Dos Santos RW(1), Martins AFL(2), Sousa-Neto SS(3), Morais MO(4), de Oliveira Moreira VHL(

Nanovesicles for Sensitive Skin Care Developed via Self-Assembly of Glutamine Linoleate.

6. J Cosmet Dermatol. 2025 Apr;24(4):e70195. doi: 10.1111/jocd.70195. Nanovesicles for Sensitive Skin Care Developed via Self-Assembly of Glutamine Linoleate. Kwon KC(1), Kim MJ(1), Yoon SA(1). Author information: (1)SEORIN COMPANY Co., Roundlab R&D Center, Seoul, Republic of Korea. BACKGROUND:

Effects of preoperative beta-hydroxy-beta-methylbutyrate, arginine, and glutamine supplementation on cardiac surgery: A randomized controlled trial.

7. Clin Nutr. 2025 Feb;45:91-100. doi: 10.1016/j.clnu.2024.12.030. Epub 2024 Dec 31. Effects of preoperative beta-hydroxy-beta-methylbutyrate, arginine, and glutamine supplementation on cardiac surgery: A randomized controlled trial. Ogawa M(1), Satomi-Kobayashi S(2), Yoshida N(3), Komaki K(4),

An open-label, randomized, controlled trial on the benefit of β-hydroxy-β-methyl butyrate, l-arginine, l-glutamine combination beverages and locomotion training as supportive care for the treatment of unresectable hepatocellular carcinoma using lenvatinib: A pilot study (HELLO study).

8. Clin Nutr ESPEN. 2025 Feb;65:357-364. doi: 10.1016/j.clnesp.2024.12.005. Epub 2024 Dec 13. An open-label, randomized, controlled trial on the benefit of β-hydroxy-β-methyl butyrate, l-arginine, l-glutamine combination beverages and locomotion training as supportive care for the treatment of u

Safety and efficacy of L-Glutamine in reducing the frequency of acute complications among patients with sickle cell disease: A randomized controlled study.

9. Ann Hematol. 2024 Sep;103(9):3493-3506. doi: 10.1007/s00277-024-05877-8. Epub 2024 Jul 19. Safety and efficacy of L-Glutamine in reducing the frequency of acute complications among patients with sickle cell disease: A randomized controlled study. Ebeid FSE(1)(2), Aly NH(3), Shaheen NM(4), Ab

Randomized Trial to Assess the Safety and Tolerability of Daily Intake of an Allulose Amino Acid-Based Hydration Beverage in Men and Women.

10. Nutrients. 2024 Jun 5;16(11):1766. doi: 10.3390/nu16111766. Randomized Trial to Assess the Safety and Tolerability of Daily Intake of an Allulose Amino Acid-Based Hydration Beverage in Men and Women. Bloomer RJ(1), Pence J(1), Hellenbrand J(1), Davis A(1), Davis S(1), Stockton M(1), Martin K

Concurrent Ingestion of Alkaline Water and L-Glutamine Enhanced Salivary α-Amylase Activity and Testosterone Concentration in Boxing Athletes.

11. Nutrients. 2024 Feb 5;16(3):454. doi: 10.3390/nu16030454. Concurrent Ingestion of Alkaline Water and L-Glutamine Enhanced Salivary α-Amylase Activity and Testosterone Concentration in Boxing Athletes. Lu TL(1), He CS(2), Suzuki K(3), Lu CC(1), Wang CY(4), Fang SH(1). Author information: (1)I

Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors.

12. Cancer Lett. 2021 Jun 1;507:13-25. doi: 10.1016/j.canlet.2021.02.020. Epub 2021 Mar 10. Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors. Prelowska MK(1), Mehlich D(2), Ugurlu MT(3), Kedzierska H(3), Cwiek A(3), Kosnik A(3), Kamin

Efficacy of Asparaginase Erwinia chrysanthemi With and Without Temozolomide Against Glioma Cells and Intracranial Mouse Medulloblastoma.

13. Anticancer Res. 2018 May;38(5):2627-2634. doi: 10.21873/anticanres.12504. Efficacy of Asparaginase Erwinia chrysanthemi With and Without Temozolomide Against Glioma Cells and Intracranial Mouse Medulloblastoma. Sanghez V(1), Chen M(1), Li S(1), Chou TF(1), Iacovino M(1), Lin HJ(1), Lasky JL(

L-glutamine (Endari) for sickle cell disease.

14. Med Lett Drugs Ther. 2018 Jan 29;60(1539):21-22. L-glutamine (Endari) for sickle cell disease. [No authors listed] PMID: 29364198 [Indexed for MEDLINE]

Minocycline enhances mitomycin C-induced cytotoxicity through down-regulating ERK1/2-mediated Rad51 expression in human non-small cell lung cancer cells.

15. Biochem Pharmacol. 2015 Oct 1;97(3):331-40. doi: 10.1016/j.bcp.2015.07.025. Epub 2015 Jul 23. Minocycline enhances mitomycin C-induced cytotoxicity through down-regulating ERK1/2-mediated Rad51 expression in human non-small cell lung cancer cells. Ko JC(1), Wang TJ(2), Chang PY(2), Syu JJ(2)

Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells.

3. Biochem Pharmacol. 2014 Mar 1;88(1):119-27. doi: 10.1016/j.bcp.2014.01.010. Epub 2014 Jan 18. Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells. Ko JC(1), Chiu HC(2), Syu JJ(2),

Polymer-attached zanamivir inhibits synergistically both early and late stages of influenza virus infection.

28. Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20385-90. doi: 10.1073/pnas.1219155109. Epub 2012 Nov 26. Polymer-attached zanamivir inhibits synergistically both early and late stages of influenza virus infection. Lee CM(1), Weight AK, Haldar J, Wang L, Klibanov AM, Chen J. Author informatio

Glutamine inhibits ammonia-induced accumulation of cGMP in rat striatum limiting arginine supply for NO synthesis.

38. Neurobiol Dis. 2009 Jul;35(1):75-81. doi: 10.1016/j.nbd.2009.04.004. Epub 2009 Apr 18. Glutamine inhibits ammonia-induced accumulation of cGMP in rat striatum limiting arginine supply for NO synthesis. Hilgier W(1), Freśko I, Klemenska E, Beresewicz A, Oja SS, Saransaari P, Albrecht J, Ziel

Protective effects of amifostine and cyclooxygenase-1 inhibitor against normal human epidermal keratinocyte toxicity induced by methotrexate and 5-fluorouracil.

11. Basic Clin Pharmacol Toxicol. 2009 Jul;105(1):1-9. doi: 10.1111/j.1742-7843.2009.00400.x. Epub 2009 Apr 3. Protective effects of amifostine and cyclooxygenase-1 inhibitor against normal human epidermal keratinocyte toxicity induced by methotrexate and 5-fluorouracil. Maiguma T(1), Kaji H, M

Astrocyte-conditioned medium protecting hippocampal neurons in primary cultures against corticosterone-induced damages via PI3-K/Akt signal pathway.

48. Brain Res. 2006 Oct 9;1114(1):1-10. doi: 10.1016/j.brainres.2006.07.070. Epub 2006 Aug 23. Astrocyte-conditioned medium protecting hippocampal neurons in primary cultures against corticosterone-induced damages via PI3-K/Akt signal pathway. Zhu ZH(1), Yang R, Fu X, Wang YQ, Wu GC. Author inf

Acetaldehyde disrupts tight junctions and adherens junctions in human colonic mucosa: protection by EGF and L-glutamine.

3. Am J Physiol Gastrointest Liver Physiol. 2005 Aug;289(2):G367-75. doi: 10.1152/ajpgi.00464.2004. Epub 2005 Feb 17. Acetaldehyde disrupts tight junctions and adherens junctions in human colonic mucosa: protection by EGF and L-glutamine. Basuroy S(1), Sheth P, Mansbach CM, Rao RK. Author infor

The 'diet heart' hypothesis in secondary prevention of coronary heart disease.

45. Eur Heart J. 1997 Jan;18(1):13-8. doi: 10.1093/oxfordjournals.eurheartj.a015094. The 'diet heart' hypothesis in secondary prevention of coronary heart disease. de Lorgeril M(1), Salen P, Monjaud I, Delaye J. Author information: (1)CERMEP CNRS UMR 1216, Lyon, France. From this detailed analys

Evidence and gaps in clinical outcomes of novel pharmacologic therapies for sickle cell disease: A systematic literature review highlighting insights from clinical trials and real-world studies.

43. Blood Rev. 2025 Aug;73:101298. doi: 10.1016/j.blre.2025.101298. Epub 2025 Apr 25. Evidence and gaps in clinical outcomes of novel pharmacologic therapies for sickle cell disease: A systematic literature review highlighting insights from clinical trials and real-world studies. Yassin M(1), M

Update on the treatment of chemotherapy and radiotherapy-induced buccal mucositis: a systematic review.

43. Acta Odontol Latinoam. 2023 Apr 29;36(1):3-14. doi: 10.54589/aol.36/1/3. Update on the treatment of chemotherapy and radiotherapy-induced buccal mucositis: a systematic review. Wen S(1)(2), Brito L(1)(2), Santander J(1)(3), Conteras G(1)(3). Author information: (1)Universidad Autónoma de Chi

Health-Related Quality of Life and Adherence to Hydroxyurea and Other Disease-Modifying Therapies among Individuals with Sickle Cell Disease: A Systematic Review.

27. Biomed Res Int. 2022 Jul 18;2022:2122056. doi: 10.1155/2022/2122056. eCollection 2022. Health-Related Quality of Life and Adherence to Hydroxyurea and Other Disease-Modifying Therapies among Individuals with Sickle Cell Disease: A Systematic Review. Yang M(1), Elmuti L(2), Badawy SM(3)(4).

Dexamethasone and Nutraceutical Therapy Can Reduce the Myalgia Due to COVID-19 - a Systemic Review of the Active Substances that Can Reduce the Expression of Interlukin-6.

12. Med Arch. 2022 Feb;76(1):66-71. doi: 10.5455/medarh.2022.76.66-71. Dexamethasone and Nutraceutical Therapy Can Reduce the Myalgia Due to COVID-19 - a Systemic Review of the Active Substances that Can Reduce the Expression of Interlukin-6. Ripani U(1), Bisaccia M(2), Meccariello L(3). Author

Metabolomics in Diabetic Retinopathy: A Systematic Review.

30. Invest Ophthalmol Vis Sci. 2021 Aug 2;62(10):4. doi: 10.1167/iovs.62.10.4. Metabolomics in Diabetic Retinopathy: A Systematic Review. Hou XW(1), Wang Y(1), Pan CW(1). Author information: (1)School of Public Health, Medical College of Soochow University, Suzhou, China. PURPOSE: Diabetic reti

The Impact of Amino Acids on Postprandial Glucose and Insulin Kinetics in Humans: A Quantitative Overview.

45. Nutrients. 2020 Oct 21;12(10):3211. doi: 10.3390/nu12103211. The Impact of Amino Acids on Postprandial Glucose and Insulin Kinetics in Humans: A Quantitative Overview. Sloun BV(1)(2), Goossens GH(1)(3), Erdos B(1)(2), Lenz M(4)(5), Riel NV(6), Arts ICW(1)(2)(7). Author information: (1)TiFN,

Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysis.

6. BMJ Open. 2020 Sep 17;10(9):e034147. doi: 10.1136/bmjopen-2019-034147. Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysis. Thom H(1), Jansen J(2), Shafrin J(2), Zhao L(2), Joseph G(3), Cheng HY(4), Gupta S(3), Shah N(5). Author in

Systematic Review of Crizanlizumab: A New Parenteral Option to Reduce Vaso-occlusive Pain Crises in Patients with Sickle Cell Disease.

4. Pharmacotherapy. 2020 Jun;40(6):535-543. doi: 10.1002/phar.2409. Epub 2020 May 20. Systematic Review of Crizanlizumab: A New Parenteral Option to Reduce Vaso-occlusive Pain Crises in Patients with Sickle Cell Disease. Han J(1)(2)(3), Saraf SL(2), Gordeuk VR(2). Author information: (1)Departm